CapsoVision, Inc. (CV) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

CapsoVision, Inc. (CV) operates in the Healthcare sector, specifically the Medical - Equipment & Services industry, with a market capitalization near $336.8M, listed on NASDAQ, employing roughly 90 people, carrying a beta of -2.62 to the broader market. Medical‑technology company developing advanced capsule endoscopy systems (CapsoCam Plus, CapsoCam Colon) and AI-enabled imaging platforms for gastrointestinal diagnostics Led by Kang-Huai Wang, public since 2001-09-03.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for CV as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →